Preoperative Disclosure of Resident Roles in Cataract Surgery in Teaching Centers

Preoperative Disclosure of Resident Roles in Cataract Surgery in Teaching Centers

Episoder(125)

Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program

Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program

Interview with Jeannette R. Wong, MPH, author of Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program

10 Apr 20145min

Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial

Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial

Interview with Desmond Cheng, OD, MSc, PhD, author of Effect of Bifocal and Prismatic Bifocal Spectacles on Myopia Progression in Children: Three-Year Results of a Randomized Clinical Trial

16 Jan 20146min

Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition

Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition

Interview with Stacy L. Pineles, MD, author of Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition

14 Nov 20136min

Socioeconomic Disparity in Use of Eye Care Services Among US Adults With Age-Related Eye Diseases

Socioeconomic Disparity in Use of Eye Care Services Among US Adults With Age-Related Eye Diseases

Interview with Jinan Saaddine, MD, MPH, author of Socioeconomic Disparity in Use of Eye Care Services Among US Adults With Age-Related Eye Diseases

12 Sep 20138min

Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

Interview with Emily Y. Chew, MD, author of Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

11 Jul 20136min

Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

Interview with Sheila K. West, PhD, author of Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma? PRET Ziada Trial Results

11 Apr 201311min

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Interview with Johanna M. Seddon, MD, ScM, author of Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

14 Feb 201311min

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Interview with Ronald Klein, MD, MPH, author of Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

9 Nov 20126min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
jss
liberal-halvtime
rss-rekommandert
sinnsyn
forskningno
villmarksliv
rss-paradigmepodden
fjellsportpodden
dekodet-2
pod-britannia
rss-overskuddsliv
tidlose-historier
hva-er-greia-med
tomprat-med-gunnar-tjomlid
katastrofe-i-hjernen
rss-lundqvist-podden
rss-nysgjerrige-norge